Home The Word Brain	My Amedeo FAQ Privacy About
	C49 In our changing world, speaking just English isn't enough. Open new doors with skills in another world language. Start with 7 words a day. Next week: +49.

Obstructive Lung Diseases

Free Subscription Articles published in Respir Res Retrieve available abstracts of 151 articles: HTML format

Single Articles

May 2025
1. LI W, Yang Q, Chen Y, Sun Y, et al
   Angiotensin receptor blockers use and lung cancer risk in Chinese patients with chronic obstructive pulmonary disease: a population-based cohort study.
   Respir Res. 2025;26:186.
   PubMed     Abstract available
   
   
   
2. ZHAO L, Wu W, Chen G, Huang C, et al
   SERPINB10 promotes macrophage M2 polarization and airway inflammation in asthma.
   Respir Res. 2025;26:181.
   PubMed     Abstract available
   
   
   
3. SINGH D, Bafadhel M, Arya N, Marshall J, et al
   Step up to triple therapy versus switch to dual bronchodilator therapy in patients with COPD on an inhaled corticosteroid/long-acting beta(2)-agonist: post-hoc analyses of KRONOS.
   Respir Res. 2025;26:175.
   PubMed     Abstract available
   
   
   
4. TIAN J, Zhang Q, Peng M, Guo L, et al
   Exhaled volatile organic compounds as novel biomarkers for early detection of COPD, asthma, and PRISm: a cross-sectional study.
   Respir Res. 2025;26:173.
   PubMed     Abstract available
   
   
   April 2025
5. CARDENAS VJ JR, Seashore JB, Tapryal N, Ameri M, et al
   Low levels of DNA repair enzyme NEIL2 May exacerbate inflammation and genomic damage in subjects with stable COPD and during severe exacerbations.
   Respir Res. 2025;26:165.
   PubMed     Abstract available
   
   
   
6. ZHOU Y, Wu F, Deng Z, Wang Z, et al
   Lung function decline and incidence of chronic obstructive pulmonary disease in participants with spirometry-defined small airway dysfunction: a 15-year prospective cohort study in China.
   Respir Res. 2025;26:169.
   PubMed     Abstract available
   
   
   
7. LI B, Liu J, Cao Y, Wang Y, et al
   Multi-omics characterization of early chronic obstructive pulmonary disease.
   Respir Res. 2025;26:167.
   PubMed     Abstract available
   
   
   
8. JIANG H, Jiang Y, Dong R, Fu CY, et al
   ETS2 aggravate allergic airway inflammation by regulating ANT2-mediated cytosolic mitochondrial DsRNA levels.
   Respir Res. 2025;26:159.
   PubMed     Abstract available
   
   
   
9. FERREIRA DH, Ryan R, Smyth N, Clow A, et al
   The longitudinal impact of low-dose morphine on diurnal cortisol profiles in people with chronic breathlessness and chronic obstructive pulmonary disease (COPD): an exploratory study.
   Respir Res. 2025;26:156.
   PubMed     Abstract available
   
   
   
10. YI E, Li H, Liu Y, Li Q, et al
    An integrated machine learning model of transcriptomic genes in multi-center chronic obstructive pulmonary disease reveals the causal role of TIMP4 in airway epithelial cell.
    Respir Res. 2025;26:158.
    PubMed     Abstract available
    
    
    
11. ZHANG Y, Lang L, Guo X, Huang K, et al
    The association and impact of radiographic, pathological emphysema and spirometric airway obstruction on patients with resectable lung adenocarcinoma.
    Respir Res. 2025;26:151.
    PubMed     Abstract available
    
    
    
12. TERADA S, Tanabe N, Maetani T, Shiraishi Y, et al
    Antigravity muscle density on computed tomography and health-related independence in normal weight patients with chronic obstructive pulmonary disease.
    Respir Res. 2025;26:143.
    PubMed     Abstract available
    
    
    
13. PINKSTON RI, Schexnayder M, Perveen Z, Langohr IM, et al
    MMP12 deficiency attenuates menthol e-cigarette plus house dust-mite effects on pulmonary iron homeostasis and oxidative stress.
    Respir Res. 2025;26:135.
    PubMed     Abstract available
    
    
    
14. AHN SY, Ho TL, Ko EJ
    Evaluation of the influenza vaccine protection in the house dust mite-induced chronic allergic asthma mice model and the evaluation of squalene oil in water emulsion as an adjuvant candidate.
    Respir Res. 2025;26:132.
    PubMed     Abstract available
    
    
    
15. ZHANG J, Luo W, Cui Y, Sun B, et al
    B-cell epitope peptide immunotherapy alleviates chitin-binding protein-induced type 2 airway inflammation in a Blomia tropicalis-murine model.
    Respir Res. 2025;26:129.
    PubMed     Abstract available
    
    
    
16. CONLEY HE, Davis KU, Adler KB, Lavoie JP, et al
    MARCKS protein is a potential target in a naturally occurring equine model of neutrophilic asthma.
    Respir Res. 2025;26:126.
    PubMed     Abstract available
    
    
    
17. MOFFETT AT, Halpern SD, Weissman GE
    The effect of a post-bronchodilator FEV(1)/FVC < 0.7 on COPD diagnosis and treatment: a regression discontinuity design.
    Respir Res. 2025;26:122.
    PubMed     Abstract available
    
    
    March 2025
18. GOODALL E, Rothnie KJ, Numbere B, Zhang S, et al
    Describing the burden of moderate exacerbations in patients with asthma from the Extended Salford Lung Study (Ext-SLS): a retrospective cohort study.
    Respir Res. 2025;26:121.
    PubMed     Abstract available
    
    
    
19. KIM SH, Lee H, Kim MJ, Kim Y, et al
    Risk of acute exacerbation of chronic obstructive pulmonary disease after COVID-19 recovery: a nationwide population-based cohort study.
    Respir Res. 2025;26:116.
    PubMed     Abstract available
    
    
    
20. LIN Z, Liu S, Zhang K, Feng T, et al
    Molecular mechanisms and therapeutic targets of acute exacerbations of chronic obstructive pulmonary disease with Pseudomonas aeruginosa infection.
    Respir Res. 2025;26:115.
    PubMed     Abstract available
    
    
    
21. STAPLES KJ, Ackland J, Lukose S, Angermann B, et al
    Lung IL-13 gene signatures are associated with raised tissue eosinophils in COPD.
    Respir Res. 2025;26:114.
    PubMed     Abstract available
    
    
    
22. KIM JM, Hwang S, Cho HW, Kim Y, et al
    Two novel genetic variants in the WFDC2 gene from patients with bronchiectasis.
    Respir Res. 2025;26:108.
    PubMed     Abstract available
    
    
    
23. ADLER A, Bergwik J, Padra M, Papareddy P, et al
    Pharmacological inhibition of MutT homolog 1 (MTH1) in allergic airway inflammation as a novel treatment strategy.
    Respir Res. 2025;26:101.
    PubMed     Abstract available
    
    
    
24. GONG G, Shen S, Shen S, Wang R, et al
    YAP/TAZ-mediated nuclear membrane rupture in promoting senescence of skeletal muscle associated with COPD.
    Respir Res. 2025;26:98.
    PubMed     Abstract available
    
    
    
25. HUANG X, Qin H, Zhang R, Jia X, et al
    Neutrophils are involved in the development and outcomes of plastic bronchitis associated with Mycoplasma pneumoniae pneumonia.
    Respir Res. 2025;26:92.
    PubMed     Abstract available
    
    
    
26. SMITH C, Hasselgren M, Sandelowsky H, Stallberg B, et al
    Disproportionately raised risk of adverse outcomes in patients with COPD and comorbid type 2 diabetes or depression: Swedish register-based cohort study.
    Respir Res. 2025;26:84.
    PubMed     Abstract available
    
    
    February 2025
27. BERTOLINI F, Carriero VMA, Arrigo E, Guida G, et al
    Vascular remodeling and TSLP/angiogenin overexpression in severe mixed asthma.
    Respir Res. 2025;26:78.
    PubMed     Abstract available
    
    
    
28. ZHU W, Han L, He L, Peng W, et al
    Lsm2 is critical to club cell proliferation and its inhibition aggravates COPD progression.
    Respir Res. 2025;26:71.
    PubMed     Abstract available
    
    
    
29. WARDEN DE, Zhang H, Jiang Y, Arshad HS, et al
    The role of wheezing subtypes in the development of early childhood asthma.
    Respir Res. 2025;26:79.
    PubMed     Abstract available
    
    
    
30. LIN G, Wei Y, Guo Z, Wang H, et al
    Short- and long-term comparative effectiveness of nirmatrelvir/ritonavir and molnupiravir in asthma patients: a cohort study.
    Respir Res. 2025;26:75.
    PubMed     Abstract available
    
    
    
31. HUO Y, He S, Chen Y
    Lung organoids in COPD: recent advances and future prospects.
    Respir Res. 2025;26:76.
    PubMed     Abstract available
    
    
    
32. WANG Y, Xiao J, Yang X, Liu Y, et al
    Pulmonary microbiology and microbiota in adults with non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis.
    Respir Res. 2025;26:77.
    PubMed     Abstract available
    
    
    
33. LI N, Xu Y, Xiao X, Ding Z, et al
    Long-term trends in the burden of asthma in China: a joinpoint regression and age-period-cohort analysis based on the GBD 2021.
    Respir Res. 2025;26:56.
    PubMed     Abstract available
    
    
    
34. GUO Y, Zhou Y, Wang R, Lin Y, et al
    YAP as a potential therapeutic target for myofibroblast formation in asthma.
    Respir Res. 2025;26:51.
    PubMed     Abstract available
    
    
    
35. WANG Z, Zhao P, Yan G, Sun A, et al
    Neuropeptide S and its receptor aggravated asthma via TFEB dependent autophagy in bronchial epithelial cells.
    Respir Res. 2025;26:50.
    PubMed     Abstract available
    
    
    
36. BURNS AJ, Steinberg AW, Sargent JD, Ozga JE, et al
    Association of e-cigarette and cigarette use with self-reported chronic obstructive pulmonary disease (COPD): a multivariable analysis of a large United States data set.
    Respir Res. 2025;26:49.
    PubMed     Abstract available
    
    
    
37. LUO T, Ji W, Gong Y, Chen L, et al
    REDD1 mediates HDM-induced nuclear-cytoplasmic translocation and release of IL-33 in airway epithelial cells by downregulating Nrf2.
    Respir Res. 2025;26:47.
    PubMed     Abstract available
    
    
    January 2025
38. LI D, Shi X, Yang Y, Deng Y, et al
    Targeting BRD4 ameliorates experimental emphysema by disrupting super-enhancer in polarized alveolar macrophage.
    Respir Res. 2025;26:46.
    PubMed     Abstract available
    
    
    
39. GOPALAKRISHNAN V, Sparklin B, Kim JH, Bouquet J, et al
    NTHi killing activity is reduced in COPD patients and is associated with a differential microbiome.
    Respir Res. 2025;26:45.
    PubMed     Abstract available
    
    
    
40. DE VOLDER J, Bontinck A, Haelterman V, Boon L, et al
    Anti-IL-5 treatment, but not neutrophil interference, attenuates inflammation in a mixed granulocytic asthma mouse model, elicited by air pollution.
    Respir Res. 2025;26:43.
    PubMed     Abstract available
    
    
    
41. MOORE CM, Thornburg J, Secor EA, Hamlington KL, et al
    Comparative analysis of ambient, in-home, and personal exposures reveals associations between breathing zone pollutant levels and asthma exacerbations in high-risk children.
    Respir Res. 2025;26:40.
    PubMed     Abstract available
    
    
    
42. TIWARI A, Hobbs BD, Sharma R, Li J, et al
    Peripheral blood miRNAs are associated with airflow below threshold in children with asthma.
    Respir Res. 2025;26:38.
    PubMed     Abstract available
    
    
    
43. BOUYSSI A, Trecourt A, Demeautis T, Persat F, et al
    Aspergillus fumigatus is responsible for inflammation in a murine model of chronic obstructive pulmonary disease exacerbation.
    Respir Res. 2025;26:25.
    PubMed     Abstract available
    
    
    
44. DOMINGUEZ-DE-BARROS A, Perez-Rubio G, Fricke-Galindo I, Ramirez-Venegas A, et al
    Shorter telomere length in COPD cases secondary to biomass-burning smoke exposure.
    Respir Res. 2025;26:23.
    PubMed     Abstract available
    
    
    
45. CHEN X, Shang Y, Shen D, Shi S, et al
    Potential drug targets for asthma identified through mendelian randomization analysis.
    Respir Res. 2025;26:16.
    PubMed     Abstract available
    
    
    
46. PARK HS, Lee J, Kim H, Woo SD, et al
    Comparative analysis of real-world data on the efficacy and safety of and adherence to ICS/LABA combinations in asthma management.
    Respir Res. 2025;26:12.
    PubMed     Abstract available
    
    
    
47. ERIKSSON STROM J, Kebede Merid S, Linder R, Pourazar J, et al
    Airway MMP-12 and DNA methylation in COPD: an integrative approach.
    Respir Res. 2025;26:10.
    PubMed     Abstract available
    
    
    
48. WANG R, Li Y, Jiang Y, Liu X, et al
    Interaction study of the effects of environmental exposure and gene polymorphisms of inflammatory and immune-active factors on chronic obstructive pulmonary disease.
    Respir Res. 2025;26:5.
    PubMed     Abstract available
    
    
    
49. MISIUKIEWICZ-STEPIEN P, Zajusz-Zubek E, Gorska K, Krenke R, et al
    The different response of PM(2.5) stimulated nasal epithelial spheroids in control, asthma and COPD groups.
    Respir Res. 2025;26:8.
    PubMed     Abstract available
    
    
    
50. DITTRICH AS, De Pace CC, Brock JM, Trudzinski F, et al
    Outcome and safety 90 days after combined airway valve treatment of the right upper and middle lobes in patients with severe pulmonary emphysema.
    Respir Res. 2025;26:4.
    PubMed     Abstract available
    
    
    
51. WANG Z, Lin J, Liang L, Huang F, et al
    Global, regional, and national burden of chronic obstructive pulmonary disease and its attributable risk factors from 1990 to 2021: an analysis for the Global Burden of Disease Study 2021.
    Respir Res. 2025;26:2.
    PubMed     Abstract available
    
    
    December 2024
52. RODRIGUES G, Antao J, Deng Q, Baak BN, et al
    Trends in initial pharmacological COPD treatment in primary care (2010-2021): a population-based study using the PHARMO Data Network.
    Respir Res. 2024;25:447.
    PubMed     Abstract available
    
    
    
53. KIM E, Leem AY, Jung JY, Kim YS, et al
    Changes in muscle-to-fat ratio are associated with lung function decline and airflow obstruction in the general population.
    Respir Res. 2024;25:444.
    PubMed     Abstract available
    
    
    
54. TANG H, Li Z, Yang C, Fu L, et al
    CTSS contributes to airway neutrophilic inflammation in mixed granulocytic asthma.
    Respir Res. 2024;25:441.
    PubMed     Abstract available
    
    
    
55. HAEUSSLER K, Ismaila AS, Malmenas M, Noorduyn SG, et al
    Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for clinicians.
    Respir Res. 2024;25:438.
    PubMed     Abstract available
    
    
    
56. KUNITOMO Y, Woo H, Balasubramanian A, Fawzy A, et al
    Longitudinal anemia status and risk for adverse outcomes in former smokers with COPD.
    Respir Res. 2024;25:437.
    PubMed     Abstract available
    
    
    
57. PENUELAS O, Del Campo-Albendea L, Morales-Quinteros L, Muriel A, et al
    A worldwide assessment of the mechanical ventilation in patients with acute exacerbations of chronic obstructive pulmonary disease. Analysis of the VENTILAGROUP over time. A retrospective, multicenter study.
    Respir Res. 2024;25:434.
    PubMed     Abstract available
    
    
    
58. FENG H, Li Z, Zheng R
    Bexarotene ameliorated the pulmonary inflammation and M1 polarization of alveolar macrophages induced by cigarette smoke via PPARgamma/HO-1.
    Respir Res. 2024;25:431.
    PubMed     Abstract available
    
    
    
59. RAO X, Luo H, Luo K, Hu C, et al
    Silencing SMAD4 inhibits inflammation and ferroptosis in asthma by blocking the IL-17A signaling pathway.
    Respir Res. 2024;25:429.
    PubMed     Abstract available
    
    
    November 2024
60. KIM OH, Lee KN, Han K, Cho IY, et al
    Association between metabolic syndrome and chronic obstructive pulmonary disease development in young individuals: a nationwide cohort study.
    Respir Res. 2024;25:414.
    PubMed     Abstract available
    
    
    
61. FAN R, Qian H, Xu JY, Wang JY, et al
    Association of asthma and bronchiectasis: Mendelian randomization analyses and observational study.
    Respir Res. 2024;25:413.
    PubMed     Abstract available
    
    
    
62. XU Z, Li F, Xin Y, Wang Y, et al
    Prognostic risk prediction model for patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD): a systematic review and meta-analysis.
    Respir Res. 2024;25:410.
    PubMed     Abstract available
    
    
    
63. NATH S, Qurashi H, Kitsios GD, Bain W, et al
    Clinical and biologic profiles of patients with acute respiratory distress syndrome by prevalence of chronic obstructive pulmonary disease or emphysema; a cohort study.
    Respir Res. 2024;25:400.
    PubMed     Abstract available
    
    
    October 2024
64. AMBHORE NS, Balraj P, Kumar A, Reza MI, et al
    Kiss1 receptor knockout exacerbates airway hyperresponsiveness and remodeling in a mouse model of allergic asthma.
    Respir Res. 2024;25:387.
    PubMed     Abstract available
    
    
    
65. ZHANG J, Zhao D, Zhang L, Feng X, et al
    Impact of HHIP gene polymorphisms on phenotypes, serum IL-17 and IL-18 in COPD patients of the Chinese Han population.
    Respir Res. 2024;25:386.
    PubMed     Abstract available
    
    
    
66. SUN J, Tong X, Wang D, Wang L, et al
    Multi-drug resistant Pseudomonas aeruginosa isolation is an independent risk factor for recurrent hemoptysis after bronchial artery embolization in patients with idiopathic bronchiectasis: a retrospective cohort study.
    Respir Res. 2024;25:385.
    PubMed     Abstract available
    
    
    
67. GOVONI M, Bassi M, Girardello L, Lucci G, et al
    CHF6523 data suggest that the phosphoinositide 3-kinase delta isoform is not a suitable target for the management of COPD.
    Respir Res. 2024;25:380.
    PubMed     Abstract available
    
    
    
68. LAI YT, Tsai YH, Hsieh MJ, Chen NH, et al
    Benefit of dual bronchodilator therapy on exacerbations in former and current smokers with chronic obstructive pulmonary disease in real-world clinical practice: a multicenter validation study (TOReTO).
    Respir Res. 2024;25:377.
    PubMed     Abstract available
    
    
    
69. YAO LP, Wang ZK, Jiang XQ, Jiang B, et al
    MiR-1307-5p enhances fibroblast transdifferentiation to exacerbate chronic obstructive pulmonary disease through regulating FBXL16/HIF1alpha axis.
    Respir Res. 2024;25:376.
    PubMed     Abstract available
    
    
    
70. WATZ H, Kirsten AM, Ludwig-Sengpiel A, Krull M, et al
    Effects of inhaled beclometasone dipropionate/formoterol fumarate/glycopyrronium vs. beclometasone dipropionate/formoterol fumarate and placebo on lung hyperinflation and exercise endurance in chronic obstructive pulmonary disease: a randomised contro
    Respir Res. 2024;25:378.
    PubMed     Abstract available
    
    
    
71. MCDUFFIE EL, Panettieri RA Jr, Scott CP
    Correction to: G(12/13) signaling in asthma.
    Respir Res. 2024;25:371.
    PubMed    
    
    
    
72. LIU Y, Yin Q, Liu B, Lu Z, et al
    Fisetin reduces ovalbumin-triggered airway remodeling by preventing phenotypic switching of airway smooth muscle cells.
    Respir Res. 2024;25:370.
    PubMed     Abstract available
    
    
    
73. GOETEYN E, Taylor SL, Dicker A, Bolle L, et al
    Aggregatibacter is inversely associated with inflammatory mediators in sputa of patients with chronic airway diseases and reduces inflammation in vitro.
    Respir Res. 2024;25:368.
    PubMed     Abstract available
    
    
    
74. CAMINATI M, Vatrella A, Rogliani P, Carpagnano E, et al
    Tezepelumab for severe asthma: elevating current practice to recognize epithelial driven profiles.
    Respir Res. 2024;25:367.
    PubMed     Abstract available
    
    
    
75. DEAN J, Fowler SJ, Singh D, Beech A, et al
    Expiratory flow limitation development index (ELDI): a novel method of assessing respiratory mechanics in COPD.
    Respir Res. 2024;25:357.
    PubMed     Abstract available
    
    
    September 2024
76. TAO X, Xu Z, Tian H, He J, et al
    Differential proteins from EVs identification based on tandem mass tags analysis and effect of Treg-derived EVs on T-lymphocytes in COPD patients.
    Respir Res. 2024;25:349.
    PubMed     Abstract available
    
    
    
77. CAO W, Li J, Che L, Yang R, et al
    Single-cell transcriptomics reveals e-cigarette vapor-induced airway epithelial remodeling and injury.
    Respir Res. 2024;25:353.
    PubMed     Abstract available
    
    
    
78. EL ABD A, Dasari H, Dodin P, Trottier H, et al
    Associations between vitamin D status and biomarkers linked with inflammation in patients with asthma: a systematic review and meta-analysis of interventional and observational studies.
    Respir Res. 2024;25:344.
    PubMed     Abstract available
    
    
    
79. BONNESEN B, Eklof J, Biering-Sorensen T, Modin D, et al
    Effect of low climate impact vs. high climate impact inhalers for patients with asthma and COPD-a nationwide cohort analysis.
    Respir Res. 2024;25:339.
    PubMed     Abstract available
    
    
    
80. LU W, Aarsand R, Schotte K, Han J, et al
    Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge Summary.
    Respir Res. 2024;25:338.
    PubMed     Abstract available
    
    
    
81. SAMORODNITSKY S, Kruk M, Lock EF, Kunisaki KM, et al
    Novel approach to exploring protease activity and targets in HIV-associated obstructive lung disease using combined proteomic-peptidomic analysis.
    Respir Res. 2024;25:337.
    PubMed     Abstract available
    
    
    
82. SHEN X, Liu H
    Using machine learning for early detection of chronic obstructive pulmonary disease: a narrative review.
    Respir Res. 2024;25:336.
    PubMed     Abstract available
    
    
    
83. KIM BG, Shin SH, Lee SK, Kim SH, et al
    Risk of incident chronic obstructive pulmonary disease during longitudinal follow-up in patients with nontuberculous mycobacterial pulmonary disease.
    Respir Res. 2024;25:333.
    PubMed     Abstract available
    
    
    
84. JI HW, Kang J, Kim HC, Jung J, et al
    The association between cumulative exposure to PM(2.5) and DNA methylation measured using methyl-capture sequencing among COPD patients.
    Respir Res. 2024;25:335.
    PubMed     Abstract available
    
    
    
85. ZHOU T, Guan Y, Lin X, Zhou X, et al
    CT-based whole lung radiomics nomogram for identification of PRISm from non-COPD subjects.
    Respir Res. 2024;25:329.
    PubMed     Abstract available
    
    
    August 2024
86. ZHANG D, Pu X, Zheng M, Li G, et al
    Employing a synergistic bioinformatics and machine learning framework to elucidate biomarkers associating asthma with pyrimidine metabolism genes.
    Respir Res. 2024;25:327.
    PubMed     Abstract available
    
    
    
87. TANG F, Liu HY, He QY, Liu Y, et al
    Cobalt exposure and pulmonary function reduction in chronic obstructive pulmonary disease patients: the mediating role of club cell secretory protein.
    Respir Res. 2024;25:324.
    PubMed     Abstract available
    
    
    
88. FAHERTY L, Zhang WZ, Salih MM, Robinson EK, et al
    Transcriptomic analysis reveals distinct effects of cigarette smoke on murine airspace and bone-marrow derived macrophages.
    Respir Res. 2024;25:322.
    PubMed     Abstract available
    
    
    
89. LEONHARDI J, Dahms U, Schnarkowski B, Struck MF, et al
    Impact of radiomics features, pulmonary emphysema score and muscle mass on the rate of pneumothorax and chest tube insertion in CT-guided lung biopsies.
    Respir Res. 2024;25:320.
    PubMed     Abstract available
    
    
    
90. WU Y, Xia S, Liang Z, Chen R, et al
    Artificial intelligence in COPD CT images: identification, staging, and quantitation.
    Respir Res. 2024;25:319.
    PubMed     Abstract available
    
    
    
91. ALLARD B, Ousova O, Savitskaya Z, Levardon H, et al
    Pulmonary adaptation to repeated poly(I:C) exposure is impaired in asthmatic mice: an observational study.
    Respir Res. 2024;25:314.
    PubMed     Abstract available
    
    
    
92. BARALDO S, Bonato M, Cassia S, Casolari P, et al
    Expression of human Interferon Regulatory Factor 3 (IRF-3) in alveolar macrophages relates to clinical and functional traits in COPD.
    Respir Res. 2024;25:315.
    PubMed     Abstract available
    
    
    
93. OUYANG S, Lu P, Li J, Jin H, et al
    Inhaled tea polyphenol-loaded nanoparticles coated with platelet membranes largely attenuate asthmatic inflammation.
    Respir Res. 2024;25:311.
    PubMed     Abstract available
    
    
    
94. CHEN YF, Hou HH, Chien N, Lu KZ, et al
    The clinical impacts of lung microbiome in bronchiectasis with fixed airflow obstruction: a prospective cohort study.
    Respir Res. 2024;25:308.
    PubMed     Abstract available
    
    
    
95. GAO F, Lei J, Zhu H, Zhao L, et al
    Small airway dysfunction links asthma exacerbations with asthma control and health-related quality of life.
    Respir Res. 2024;25:306.
    PubMed     Abstract available
    
    
    
96. PATEL A, Buszkiewicz JH, Cook S, Arenberg DA, et al
    Longitudinal association of exclusive and dual use of cigarettes and cigars with asthma exacerbation among US adults: a cohort study.
    Respir Res. 2024;25:305.
    PubMed     Abstract available
    
    
    
97. SUGAWARA H, Saito A, Yokoyama S, Chiba H, et al
    Therapeutic effect of long-acting muscarinic antagonist for treating uncontrolled asthma assessed using impulse oscillometry.
    Respir Res. 2024;25:300.
    PubMed     Abstract available
    
    
    
98. LIAO K, Wang F, Xia C, Xu Z, et al
    The cGAS-STING pathway in COPD: targeting its role and therapeutic potential.
    Respir Res. 2024;25:302.
    PubMed     Abstract available
    
    
    
99. MURO S, Kawayama T, Sugiura H, Seki M, et al
    Benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate on lung function and exacerbations of COPD: a post-hoc analysis of the KRONOS study by blood eosinophil level and exacerbation history.
    Respir Res. 2024;25:297.
    PubMed     Abstract available
    
    
    
100. MCDUFFIE EL, Panettieri RA Jr, Scott CP
     G(12/13) signaling in asthma.
     Respir Res. 2024;25:295.
     PubMed     Abstract available
     
     
     
101. LIN S, Wang S, Jiang Q, Liu S, et al
     Exploring the mechanism of Lianhuaqingwen (LHQW) in treating chronic bronchitis based on network pharmacology and experimental validation.
     Respir Res. 2024;25:294.
     PubMed     Abstract available
     
     
     July 2024
102. GU W, Huang C, Chen G, Kong W, et al
     The role of extracellular traps released by neutrophils, eosinophils, and macrophages in asthma.
     Respir Res. 2024;25:290.
     PubMed     Abstract available
     
     
     
103. WAN M, Yu Q, Xu F, You LX, et al
     Novel hypoxia-induced HIF-1alphaactivation in asthma pathogenesis.
     Respir Res. 2024;25:287.
     PubMed     Abstract available
     
     
     
104. DUAN JL, Li CY, Jiang Y, Liu C, et al
     Microbiological characteristics of the lower airway in adults with bronchiectasis: a prospective cohort study.
     Respir Res. 2024;25:283.
     PubMed     Abstract available
     
     
     
105. MARTIN R, Nora M, Anna L, Olivia P, et al
     Altered hypoxia-induced cellular responses and inflammatory profile in lung fibroblasts from COPD patients compared to control subjects.
     Respir Res. 2024;25:282.
     PubMed     Abstract available
     
     
     
106. FRAJMAN A, Izhakian S, Mekiten O, Hadar O, et al
     Phenotypical characteristics of nontuberculous mycobacterial infection in patients with bronchiectasis.
     Respir Res. 2024;25:278.
     PubMed     Abstract available
     
     
     
107. TRUDZINSKI FC, Jorres RA, Alter P, Watz H, et al
     Midregional Proatrial Natriuretic Peptide (MRproANP) is associated with vertebral fractures and low bone density in patients with chronic obstructive pulmonary disease (COPD).
     Respir Res. 2024;25:274.
     PubMed     Abstract available
     
     
     
108. VINCENT-GALTIE N, Marquant Q, Catherinot E, Ackermann F, et al
     Tezepelumab for refractory eosinophilic granulomatosis with polyangiitis-related asthma.
     Respir Res. 2024;25:272.
     PubMed     Abstract available
     
     
     
109. LIU X, Zhang J, Zhang D, Pan Y, et al
     Necroptosis plays a role in TL1A-induced airway inflammation and barrier damage in asthma.
     Respir Res. 2024;25:271.
     PubMed     Abstract available
     
     
     June 2024
110. HOCHHAUSEN N, Mechelinck M, Kroh A, Rossaint R, et al
     Chronic obstructive pulmonary disease affects outcome in surgical patients with perioperative organ injury: a retrospective cohort study in Germany.
     Respir Res. 2024;25:251.
     PubMed     Abstract available
     
     
     
111. OZALTIN B, Chapman R, Arfeen MQU, Fitzpatick N, et al
     Delineating excess comorbidities in idiopathic pulmonary fibrosis: an observational study.
     Respir Res. 2024;25:249.
     PubMed     Abstract available
     
     
     
112. EKLOF J, Alispahic IA, Armbruster K, Lapperre TS, et al
     Systemic antibiotics for Pseudomonas aeruginosa infection in outpatients with non-hospitalised exacerbations of pre-existing lung diseases: a randomised clinical trial.
     Respir Res. 2024;25:236.
     PubMed     Abstract available
     
     
     
113. ZENG R, Zhang D, Zhang J, Pan Y, et al
     Targeting lysyl oxidase like 2 attenuates OVA-induced airway remodeling partly via the AKT signaling pathway.
     Respir Res. 2024;25:230.
     PubMed     Abstract available
     
     
     May 2024
114. PARK JE, Lee E, Singh D, Kim EK, et al
     The effect of inhaler prescription on the development of lung cancer in COPD: a nationwide population-based study.
     Respir Res. 2024;25:229.
     PubMed     Abstract available
     
     
     
115. ZHOU L, Roth M, Papakonstantinou E, Tamm M, et al
     Expression of glucocorticoid receptor and HDACs in airway smooth muscle cells is associated with response to steroids in COPD.
     Respir Res. 2024;25:227.
     PubMed     Abstract available
     
     
     
116. MONK PD, Brookes JL, Tear VJ, Batten TN, et al
     Nebulised interferon beta-1a (SNG001) in the treatment of viral exacerbations of COPD.
     Respir Res. 2024;25:228.
     PubMed     Abstract available
     
     
     
117. XUE H, Lan X, Xue T, Tang X, et al
     PD-1(+) T lymphocyte proportions and hospitalized exacerbation of COPD: a prospective cohort study.
     Respir Res. 2024;25:218.
     PubMed     Abstract available
     
     
     
118. MOTTA H, Reuwsaat JCV, Lopes FC, Viezzer G, et al
     Comparative microbiome analysis in cystic fibrosis and non-cystic fibrosis bronchiectasis.
     Respir Res. 2024;25:211.
     PubMed     Abstract available
     
     
     
119. FRANTZI N, Nguyen XP, Herr C, Alter P, et al
     Statins did not reduce the frequency of exacerbations in individuals with COPD and cardiovascular comorbidities in the COSYCONET cohort.
     Respir Res. 2024;25:207.
     PubMed     Abstract available
     
     
     
120. CADHAM CJ, Oh H, Han MK, Mannino D, et al
     The prevalence and mortality risks of PRISm and COPD in the United States from NHANES 2007-2012.
     Respir Res. 2024;25:208.
     PubMed     Abstract available
     
     
     
121. LAIMAN V, Chuang HC, Lo YC, Yuan TH, et al
     Cigarette smoke-induced dysbiosis: comparative analysis of lung and intestinal microbiomes in COPD mice and patients.
     Respir Res. 2024;25:204.
     PubMed     Abstract available
     
     
     
122. AU-DOUNG PLW, Chan JCH, Kui OYH, Ho MKY, et al
     Objective monitoring tools for improved management of childhood asthma.
     Respir Res. 2024;25:194.
     PubMed     Abstract available
     
     
     April 2024
123. XU MM, Kang JY, Wang QY, Zuo X, et al
     Melatonin improves influenza virus infection-induced acute exacerbation of COPD by suppressing macrophage M1 polarization and apoptosis.
     Respir Res. 2024;25:186.
     PubMed     Abstract available
     
     
     
124. SHARMA E, Lauten K, Zebrak KA, Edwards KC, et al
     Respiratory symptoms and outcomes among cigar smokers: findings from the Population Assessment of Tobacco and Health (PATH) study waves 2-5 (2014-2019).
     Respir Res. 2024;25:185.
     PubMed     Abstract available
     
     
     
125. XIANG J, Liu B, Li Y, Ren Y, et al
     TFEB regulates dendritic cell antigen presentation to modulate immune balance in asthma.
     Respir Res. 2024;25:182.
     PubMed     Abstract available
     
     
     
126. FARINHA I, Heaney LG
     Barriers to clinical remission in severe asthma.
     Respir Res. 2024;25:178.
     PubMed     Abstract available
     
     
     
127. PINKERTON JW, Preite S, Piras A, Zervas D, et al
     PI3Kgammadelta inhibition suppresses key disease features in a rat model of asthma.
     Respir Res. 2024;25:175.
     PubMed     Abstract available
     
     
     
128. WAN R, Srikaram P, Xie S, Chen Q, et al
     PPARgamma attenuates cellular senescence of alveolar macrophages in asthma-COPD overlap.
     Respir Res. 2024;25:174.
     PubMed     Abstract available
     
     
     
129. XIAO W, Chen YL, Du LY, Wu J, et al
     Bacterial interactome disturbance in chronic obstructive pulmonary disease clinical stability and exacerbations.
     Respir Res. 2024;25:173.
     PubMed     Abstract available
     
     
     
130. LIU Y, Chen F, Zeng Z, Lei C, et al
     Neopterin in patients with COPD, asthma, and ACO: association with endothelial and lung functions.
     Respir Res. 2024;25:171.
     PubMed     Abstract available
     
     
     
131. ZHU Z, Zhao S, Li J, Wang Y, et al
     Development and application of a deep learning-based comprehensive early diagnostic model for chronic obstructive pulmonary disease.
     Respir Res. 2024;25:167.
     PubMed     Abstract available
     
     
     
132. GAO J, Yang Y, Xiang X, Zheng H, et al
     Human genetic associations of the airway microbiome in chronic obstructive pulmonary disease.
     Respir Res. 2024;25:165.
     PubMed     Abstract available
     
     
     
133. KOVACH MA, Kack U, Che KF, Brundin B, et al
     Systemic IL-26 correlates with improved asthma control in children sensitized to dog allergen.
     Respir Res. 2024;25:163.
     PubMed     Abstract available
     
     
     
134. FUNG NH, Nguyen QA, Owczarek C, Wilson N, et al
     Early-life house dust mite aeroallergen exposure augments cigarette smoke-induced myeloid inflammation and emphysema in mice.
     Respir Res. 2024;25:161.
     PubMed     Abstract available
     
     
     
135. DING Y, Wang Z, Zhang Z, You R, et al
     GLUT3-mediated cigarette smoke-induced epithelial-mesenchymal transition in chronic obstructive pulmonary disease through the NF-kB/ZEB1 pathway.
     Respir Res. 2024;25:158.
     PubMed     Abstract available
     
     
     March 2024
136. BERGWIK J, Liu J, Padra M, Bhongir RKV, et al
     A novel quinoline with airway relaxant effects and anti-inflammatory properties.
     Respir Res. 2024;25:146.
     PubMed     Abstract available
     
     
     
137. KIM T, Shin SH, Kim H, Im Y, et al
     Longitudinal BMI change and outcomes in Chronic Obstructive Pulmonary Disease: a nationwide population-based cohort study.
     Respir Res. 2024;25:150.
     PubMed     Abstract available
     
     
     
138. DING H, Yan L, Wang Y, Lu Y, et al
     Astaxanthin attenuates cigarette smoke-induced small airway remodeling via the AKT1 signaling pathway.
     Respir Res. 2024;25:148.
     PubMed     Abstract available
     
     
     
139. LU L, Wu F, Peng J, Wu X, et al
     Clinical characterization and outcomes of impulse oscillometry-defined bronchodilator response: an ECOPD cohort-based study.
     Respir Res. 2024;25:149.
     PubMed     Abstract available
     
     
     
140. WU J, Meng W, Ma Y, Zhao Z, et al
     Early smoking lead to worse prognosis of COPD patients: a real world study.
     Respir Res. 2024;25:140.
     PubMed     Abstract available
     
     
     
141. HSU YT, Wu CC, Wang CC, Sheu CC, et al
     Increased di-(2-ethylhexyl) phthalate exposure poses a differential risk for adult asthma clusters.
     Respir Res. 2024;25:139.
     PubMed     Abstract available
     
     
     
142. MEI S, Li D, Wang A, Zhu G, et al
     The role of sialidase Neu1 in respiratory diseases.
     Respir Res. 2024;25:134.
     PubMed     Abstract available
     
     
     
143. SHIN SH, Kim T, Kim H, Cho J, et al
     Impact of smoking reduction on lung cancer risk in patients with COPD who smoked fewer than 30 pack-years: a nationwide population-based cohort study.
     Respir Res. 2024;25:133.
     PubMed     Abstract available
     
     
     
144. MCCLUSKEY ES, Liu N, Pandey A, Marchetti N, et al
     Quercetin improves epithelial regeneration from airway basal cells of COPD patients.
     Respir Res. 2024;25:120.
     PubMed     Abstract available
     
     
     
145. HONG X, Jiang M, Kho AT, Tiwari A, et al
     Circulating miRNAs associate with historical childhood asthma hospitalization in different serum vitamin D groups.
     Respir Res. 2024;25:118.
     PubMed     Abstract available
     
     
     
146. CAI R, Gong X, Li X, Jiang Y, et al
     Dectin-1 aggravates neutrophil inflammation through caspase-11/4-mediated macrophage pyroptosis in asthma.
     Respir Res. 2024;25:119.
     PubMed     Abstract available
     
     
     
147. LAN G, Xie M, Lan J, Huang Z, et al
     Association and mediation between educational attainment and respiratory diseases: a Mendelian randomization study.
     Respir Res. 2024;25:115.
     PubMed     Abstract available
     
     
     
148. WU Y, He B, Hua J, Hu W, et al
     Deciphering the molecular regulatory of RAB32/GPRC5A axis in chronic obstructive pulmonary disease.
     Respir Res. 2024;25:116.
     PubMed     Abstract available
     
     
     February 2024
149. MATERA MG, Rinaldi B, Calabrese C, Belardo C, et al
     The effect of combining an inhaled corticosteroid and a long-acting muscarinic antagonist on human airway epithelial cells in vitro.
     Respir Res. 2024;25:104.
     PubMed     Abstract available
     
     
     
150. BELL AJ, Pal R, Labaki WW, Hoff BA, et al
     Local heterogeneity of normal lung parenchyma and small airways disease are associated with COPD severity and progression.
     Respir Res. 2024;25:106.
     PubMed     Abstract available
     
     
     
151. SIROUX V, Boudier A, Lyon-Caen S, Quentin J, et al
     Intra-breath changes in respiratory mechanics are sensitive to history of respiratory illness in preschool children: the SEPAGES cohort.
     Respir Res. 2024;25:99.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge.